Big Pharma Stocks Plummet Amid Legal Issues Over Key Medication
Pharmaceutical companies have lost tens of billions in stock market value this week ahead of a trial regarding the heartburn drug Zantac.
The Food and Drug Administration (FDA) announced in 2019 that Zantac, the brand name for the…
Read More...
Read More...